Mediclinic Middle East has joined Hub71+ LifeSciences through a strategic partnership aimed at helping HealthTech startups develop and advance innovative healthcare solutions in Abu Dhabi.
Formalised through a Memorandum of Understanding at the Abu Dhabi Future Health Summit 2026, the collaboration will connect startups with Mediclinic’s clinical expertise and healthcare network, providing insights to refine technologies and explore their potential applications in real-world healthcare settings.
The partnership will focus on opportunities across cancer care, fertility and IVF, musculoskeletal services, chronic disease management, women’s health, virtual care, care beyond hospitals and clinical augmentation.
Click here to join our WhatsApp channel here
Hein van Eck, Chief Executive Officer of Mediclinic Middle East, said: “Innovation has an important role to play in shaping the future of healthcare, but its real value lies in how it improves the care we deliver to patients. Through our collaboration with Hub71, we want to create opportunities for promising healthcare technologies to be developed and evaluated in real clinical environments, with direct input from healthcare professionals.”
Mediclinic Middle East will also contribute to mentorship and knowledge-sharing activities, helping entrepreneurs understand clinical needs and assess how emerging technologies could improve patient care.
Basma AlBadi AlDhaheri, Head of Growth and Value Creation at Hub71, said: “Startups have significant potential to transform healthcare when given access to the right industry partners and opportunities to validate and scale their solutions. Our partnership with Mediclinic Middle East will help bridge the gap between innovation and real-world adoption, enabling startups to develop, test and bring innovative healthcare solutions to market.”
Also read: Partnership to Expand AI-Driven Healthcare Access Across the Global South
Launched in 2025, Hub71+ LifeSciences supports innovation across biotechnology, medical technology and digital health. The ecosystem connects startups with healthcare providers, regulators and investors to facilitate the development, validation and commercialisation of healthcare technologies.
The partnership is expected to strengthen links between healthcare providers and innovators, supporting the growth of Abu Dhabi’s life sciences ecosystem and the adoption of solutions addressing real clinical challenges.
